Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - The results of the United Kingdom HD3 national cohort trial

European Journal of Cancer

Volumn 48, Issue 1, 2012, Pages 108-113

  Shankar, Ananth ^a   Visaduraki, Maria ^b   Hayward, Janis ^b   Morland, Bruce ^c   McCarthy, Keith ^d   Hewitt, Martin ^e  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Adolescent; Antineoplastic combined chemotherapy protocols ad; Antineoplastic combined chemotherapy protocols tu; Child; Children; Follow up studies; Hodgkin disease dt (drug therapy); Hodgkin disease mo (mortality); Human neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CARDIOPULMONARY FUNCTION; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MENTAL DISEASE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SALVAGE THERAPY; SCHOOL CHILD; SECOND CANCER; SEIZURE; SIDE EFFECT; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; COHORT STUDIES; DACARBAZINE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HODGKIN DISEASE; HUMANS; MALE; PREDNISOLONE; PROCARBAZINE; PROGNOSIS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 83255187368     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.05.029     Document Type: Article

References (31)

1. M. Capra, M. Hewitt, and M. Radford Long term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial: Children's Cancer and Leukaemia Group Eur J Cancer 43 2007 1171 1179
2. D.C. Hodgson, M.M. Hudson, and L.S. Constine Pediatric Hodgkin lymphoma: maximizing efficacy and minimizing toxicity Semin Radiat Oncol 17 2007 230 242
3. W. Dörffel, H. Lüders, and U. Rühl Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook Klin Padiatr 215 2003 139 145
4. G. Schellong, R. Pötter, and J. Brämswig High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group J Clin Oncol 17 1999 3736 3744
5. M.S. Staege, and D. Körholz New treatment strategies for Hodgkin's lymphoma Leuk Res 33 2009 886 888
6. S.S. Donaldson, M.P. Link, and H.J. Weinstein Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease J Clin Oncol 25 2007 332 337
7. J.B. Nachman, R. Sposto, and P. Herzog Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol 20 2002 3765 3771
8. M.M. O'Brien, S.S. Donaldson, R.R. Balise, A.S. Whittemore, and M.P. Link Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy J Clin Oncol 28 2010 1232 1239
9. M.A. Alm El-Din, S.A. El-Badawy, and A.G. Taghian Breast cancer after treatment of Hodgkin's lymphoma: general review Int J Radiat Oncol Biol Phys 72 2008 1291 1297
10. A.J. Taylor, A.P. Croft, and A.M. Palace Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study Int J Cancer 125 2009 2400 2405
11. S.L. Hancock, S.S. Donaldson, and R.T. Hoppe Cardiac disease following treatment of Hodgkin's disease in children and adolescents J Clin Oncol 11 1993 1208 1215
12. P.P. Carbone, H.S. Kaplan, and K. Musshoff Report of the committee on Hodgkin's disease staging classification Cancer Res 31 1971 1860 1861
13. R.J. Lukes, and J.J. Butler The pathology and nomenclature of Hodgkin's disease Cancer Res 26 1966 1063 1083
14. E.L. Kaplan, and P. Meier Non-parametric estimation from incomplete observations J Am Statist Assn 53 1958 457 481
15. R. Peto, and J. Peto Asymptotically efficient rank invariant test procedures J Roy Statist Soc Series A (General) 135 1972 185 207
16. U. Rühl, M. Albrecht, and K. Dieckmann Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial Int J Radiat Oncol Biol Phys 51 2001 1209 1218
17. M.M. Hudson, C. Greenwald, and E. Thompson Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease J Clin Oncol 11 1993 100 108
18. O. Oberlin, G. Leverger, and H. Pacquement Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology J Clin Oncol 10 1992 1602 1608
19. R.S. Smith, Q. Chen, and M.M. Hudson Prognostic factors for children with hodgkin's disease treated with combined-modality therapy J Clin Oncol 21 2003 2026 2033
20. M.J. Krasin, S.N. Rai, and L.E. Kun Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy J Clin Oncol 23 2005 8406 8413
21. F.H. Kung, C.L. Schwartz, and C.R. Ferree Children's Oncology Group. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group J Pediatr Hematol Oncol 28 2006 362 368
22. C. Furth, T. Denecke, and I. Steffen Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease J Pediatr Hematol Oncol 28 2006 501 512
23. D. Körholz, R. Kluge, and L. Wickmann Importance of F18-fluorodeoxy-d-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol Onkologie 26 2003 489 493
24. M. Tukenova, I. Diallo, and M. Hawkins Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment Cancer Epidemiol Biomarkers Prev 19 2010 707 715
25. K.A. Goodman, E. Riedel, and V. Serrano Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma J Clin Oncol 26 2008 5240 5247
26. T. Seshadri, M. Pintilie, and J. Kuruvilla Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma Leuk Lymphoma 50 2009 380 386
27. G. Biti, E. Cellai, and S.M. Magrini Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution Int J Radiat Oncol Biol Phys 29 1994 25 31
28. F.G. Hakvoort-Cammel, S. Buitendijk, and Van den Heuvel-Eibrink Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol Pediatr Blood Cancer 43 2004 8 16
29. Shankar A, Daw S, Gorde-Grosjean S, et al. Treatment of children and adolescents with early stage nodular lymphocyte predominant hodgkin's lymphoma with a low intensity short duration chemotherapy regimen [CVP] - on behalf of the EuroNet-PHL Group ASH 2006 abstract # 2471.
30. http://www.lymphome.de/Gruppen/GPOH-HD/Protokolle/EuroNet-PHL-C1/ Synopsis.pdf.
31. B. Pellegrino, M.J. Terrier-Lacombe, and O. Oberlin Study of the French Society of Pediatric Oncology. Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection- a Study of the French Society of Pediatric Oncology J Clin Oncol 2 2003 2948 2952